Literature DB >> 23247492

Efficacy and safety of tumor necrosis factor inhibitors in acute generalized pustular psoriasis.

Manuelle Viguier, François Aubin, Emmanuel Delaporte, Cécile Pagès, Carle Paul, Marie Beylot-Barry, Catherine Goujon, Michel Rybojad, Hervé Bachelez.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23247492     DOI: 10.1001/2013.jamadermatol.80

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


× No keyword cloud information.
  5 in total

Review 1.  IL-6 as a druggable target in psoriasis: focus on pustular variants.

Authors:  Andrea Saggini; Sergio Chimenti; Andrea Chiricozzi
Journal:  J Immunol Res       Date:  2014-07-13       Impact factor: 4.818

2.  Successful treatment of juvenile generalized pustular psoriasis with infliximab therapy: two case reports.

Authors:  Jiajing Lu; Ying Li; Ning Yu; Fujuan Chen; Yangfeng Ding; Xuemei Yi
Journal:  J Int Med Res       Date:  2020-03       Impact factor: 1.671

Review 3.  Pathophysiology of Generalized Pustular Psoriasis.

Authors:  Slaheddine Marrakchi; Lluis Puig
Journal:  Am J Clin Dermatol       Date:  2022-01-21       Impact factor: 7.403

Review 4.  Treatment Options and Goals for Patients with Generalized Pustular Psoriasis.

Authors:  James Krueger; Lluís Puig; Diamant Thaçi
Journal:  Am J Clin Dermatol       Date:  2022-01-21       Impact factor: 7.403

Review 5.  Pustular Psoriasis: From Pathophysiology to Treatment.

Authors:  Giovanni Genovese; Chiara Moltrasio; Nicoletta Cassano; Carlo Alberto Maronese; Gino Antonio Vena; Angelo Valerio Marzano
Journal:  Biomedicines       Date:  2021-11-23
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.